Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/30/2009WO2009157020A1 Coumarin compounds for the treatment of cardiovascular diseases and process for preparing the same
12/30/2009WO2009157018A2 Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
12/30/2009WO2009157005A1 Crystalline forms of atorvastatin hemi-magnesium salt and a process thereof
12/30/2009WO2009156966A1 Benzothiazoles and aza-analogues thereof use as antibacterial agents
12/30/2009WO2009156951A2 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
12/30/2009WO2009156889A1 Diaryl compounds and uses thereof
12/30/2009WO2009156865A1 Substituted pyrimidin-4-one derivatives
12/30/2009WO2009156864A2 Substituted alkyl pyrimidin-4-one derivatives
12/30/2009WO2009156863A2 Substituted tricyclic derivatives
12/30/2009WO2009156861A2 Substituted pyrimidone derivatives
12/30/2009WO2009156860A2 Substituted triazinone derivatives
12/30/2009WO2009156859A1 Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives
12/30/2009WO2009156857A1 Substituted n-oxide pyrazine derivatives
12/30/2009WO2009156853A2 Compounds, compositions, and methods useful for modulating the expression of histone deacetylase (hdac) gene expression and/or activity
12/30/2009WO2009156837A2 Amorphous form of a 3-pyrrole substituted 2-indolinone malate salt
12/30/2009WO2009156796A1 Pharmaceutical compositions of rosuvastatin calcium
12/30/2009WO2009156737A1 Triazolo [4, 5-d] pyramidine derivatives and their use as purine receptor antagonists
12/30/2009WO2009156728A1 Assay
12/30/2009WO2009156724A2 Novel compounds
12/30/2009WO2009156680A2 Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders
12/30/2009WO2009156679A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid
12/30/2009WO2009156678A2 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
12/30/2009WO2009156677A2 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative
12/30/2009WO2009156676A1 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative
12/30/2009WO2009156675A2 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid
12/30/2009WO2009156544A1 Complexes of albumin with omega-9 monounsaturated fatty acids for treatment of medullary lesions
12/30/2009WO2009156535A1 Hydrazides of heterocyclic systems and use thereof in the treatment of neurodegenerative diseases
12/30/2009WO2009156484A2 Organic compounds
12/30/2009WO2009156479A1 Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
12/30/2009WO2009156462A2 Organic compounds
12/30/2009WO2009156458A1 Novel phenolic and catecholic amines and prodrugs thereof
12/30/2009WO2009156421A1 Squaric acid derivatives as inhibitors of the nicotinamide
12/30/2009WO2009156396A1 Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/30/2009WO2009156380A1 Eltoprazine for suppression of l-dopa induced dyskinesias
12/30/2009WO2009156369A1 Pharmaceutical transdermal compositions and method for treating inflammation in cattle
12/30/2009WO2009156339A1 Isoquinolinone derivatives as nk3 antagonists
12/30/2009WO2009156315A1 Pyrazolo-quinazolines
12/30/2009WO2009156284A1 Novel substituted pyridin-2-ones and pyridazin-3-ones
12/30/2009WO2009156161A1 Pharmaceutical compositions comprising aminoadamantane derivatives
12/30/2009WO2009156160A1 Pharmaceutical compositions comprising a complex of aminocyclohexane derivatives and cyclodextrin
12/30/2009WO2009156128A1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1 h-pyrrole-3-carboxamide
12/30/2009WO2009156100A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
12/30/2009WO2009156099A1 6-substituted isoquinolines and isoquinolinones
12/30/2009WO2009156092A2 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
12/30/2009WO2009156091A1 3-cyanoalkyl- and 3-hydroxyalkylindoles and use thereof
12/30/2009WO2009156089A1 Diaryl ureas for treating heart failure
12/30/2009WO2009156082A1 Oxazolidinones for the treatment of chronic obstructive pulmonary disease (copd) and/or asthma
12/30/2009WO2009156072A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
12/30/2009WO2009156071A1 Combination of amidine derivates with cyclic depsipeptides
12/30/2009WO2009156070A1 Diaryl urea for treating heart failure
12/30/2009WO2009155962A1 Use
12/30/2009WO2009155887A1 Composition of flavanolignan and amino acid with improved water solubility
12/30/2009WO2009155786A1 Amine compounds and their pharmaceutical use
12/30/2009WO2009155777A1 The use and method of the compound of fasudil and the pharmaceutical composition thereof
12/30/2009WO2009155757A1 A pharmaceutical composition containing oligosaccharide obtained from morinda root and the procedure thereof
12/30/2009WO2009155753A1 The use of inositol derivative or salts thereof in the manufacture of medicaments as glycosidase inhibitors or medicaments for treating diabetes
12/30/2009WO2009155742A1 Dextran for treating lung cancer
12/30/2009WO2009155730A1 A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe
12/30/2009WO2009155676A1 Rosmarinic acid from origanum vulgare for treatment of diabetes
12/30/2009WO2009155665A1 Methods and compositions for treating pathological infections
12/30/2009WO2009155659A1 Combination therapy
12/30/2009WO2009137782A3 Allosteric enhancers of the a1 adenosine receptor
12/30/2009WO2009137737A3 Anti-bacterial activity of 9-hydroxy derivatives of 6, 11-bicyclolides
12/30/2009WO2009137531A3 Compositions and methods related to action of low dosages of doxepin on the h1 and 5-ht2a receptors
12/30/2009WO2009137510A3 Method for protecting humans against superficial vasodilator flush syndrome
12/30/2009WO2009137465A3 Compositions for treatment or prevention of pathological cardiac remodeling and heart failure
12/30/2009WO2009137217A3 Therapeutic replenishment and enrichment of ocular surface lubrication
12/30/2009WO2009137062A3 Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same
12/30/2009WO2009137016A3 Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
12/30/2009WO2009136997A3 Inhibitors of human cathepsin l, cathepsin b, and cathepsin s
12/30/2009WO2009136995A3 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
12/30/2009WO2009135673A3 Compounds with glycidic structure active in the therapy of systemic and local inflammation
12/30/2009WO2009134899A3 Producing biofuels using polyketide synthases
12/30/2009WO2009134710A3 Methods for enhancing utrophin production via inhibition of microrna
12/30/2009WO2009134658A3 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
12/30/2009WO2009134524A3 Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
12/30/2009WO2009133458A4 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels
12/30/2009WO2009132351A3 Anti-sense microrna expression vectors
12/30/2009WO2009132082A3 Immunogenic compositions containing ceramide and methods of use thereof
12/30/2009WO2009131958A3 Compounds, compositions and methods comprising triazine derivatives
12/30/2009WO2009131957A8 Compounds, compositions and methods comprising oxadiazole derivatives
12/30/2009WO2009131654A3 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
12/30/2009WO2009130604A3 Solid state forms of deferasirox salts and process for the preparation thereof
12/30/2009WO2009130422A3 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
12/30/2009WO2009129927A8 Compositions for the treatment of vaginal infections with chronic inflammation
12/30/2009WO2009129926A8 Compositions for the treatment and prevention of infections of the oral cavity
12/30/2009WO2009127072A8 Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
12/30/2009WO2009126834A3 Combination of hgf inhibitor and egf inhibitor to treat cancer
12/30/2009WO2009126640A3 Compositions of modulators of the wnt/b-catenin pathway and an n-cinnamyl-n'-benzhydryl piperazine and their use in treating neoplastic conditions including malignant melanoma
12/30/2009WO2009124295A3 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
12/30/2009WO2009124272A3 Inhibitors of peritoneal seeding of cancer cells
12/30/2009WO2009123776A3 Antiviral drugs for treatment of arenavirus infection
12/30/2009WO2009120999A3 Use of an endoxifen prodrug for treatment of breast cancer
12/30/2009WO2009120803A3 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator
12/30/2009WO2009120700A3 Inhibition of dcps
12/30/2009WO2009120652A3 Monocyclic cgrp receptor antagonists
12/30/2009WO2009120378A3 Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
12/30/2009WO2009117831A9 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
12/30/2009WO2009117144A9 Benzazepine compounds
12/30/2009WO2009116084A3 A method for the preparation of fentanyl
1 ... 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 ... 7860